Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd. in $2.5 Million Registered Direct Offering By Sichenzia Ross Ference LLP | May 6, 2020 XTL Biopharmaceuticals Ltd. $2,500,000 Registered Direct Offering of American Depositary Shares Private Placement of Warrants February 2017 Read More
Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc. By Sichenzia Ross Ference LLP | May 6, 2020 Ampio Pharmaceuticals, Inc. $6,600,000 Registered Direct Public Offering Represented Joseph Gunnar & Co. as Lead Placement June 2017 Read More
Sichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement By Sichenzia Ross Ference LLP | May 6, 2020 Aridis Pharmaceuticals, Inc. $15,200,000 Private Placement of Common Stock and Warrants August 2016 Read More
Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $6.9 Million Private Placement By Sichenzia Ross Ference LLP | May 6, 2020 Pershing Gold Corporation $6,900,000 Private Placement of Common Stock and Warrants Represented Laidlaw & Company (UK) Ltd. as Placement Agent February 2016 Read More
Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in a $3 Million Registered Direct Offering By Sichenzia Ross Ference LLP | May 6, 2020 Amarantus BioScience Holdings, Inc. $3,000,000 Convertible Preferred Stock and Warrants February 2016 Read More